{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifruikv3qqv327cqmnivsrbezmpake3jvyxw2ypvbwg5g4mlhkztm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhbt77ohb4y2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiewmdom4askerce5cpdeymjrktmmvv5jz4abxgxt3ivqlylfh2ixy"
    },
    "mimeType": "image/jpeg",
    "size": 300636
  },
  "path": "/news/2026-03-therapy-common-bone-cancer-children.html",
  "publishedAt": "2026-03-17T15:40:12.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case Western Reserve University and University Hospitals shows some promising results. The study, published in BMC Medicine, found that a specially engineered immune-cell treatment, called OSM CAR-T, successfully attacks osteosarcoma tumors in mouse models.",
  "title": "Promising new therapy developed for most common form of bone cancer in children and young adults"
}